» Articles » PMID: 39697864

Zebrafish Navigating the Metabolic Maze: Insights into Human Disease - Assets, Challenges and Future Implications

Overview
Specialty Endocrinology
Date 2024 Dec 19
PMID 39697864
Authors
Affiliations
Soon will be listed here.
Abstract

Zebrafish () have become indispensable models for advancing our understanding of multiple metabolic disorders such as obesity, diabetes mellitus, dyslipidemia, and metabolic syndrome. This review provides a comprehensive analysis of zebrafish as a powerful tool for dissecting the genetic and molecular mechanisms of these diseases, focusing on key genes, like , , , and . Zebrafish offer distinct advantages, including genetic tractability, optical transparency in early development, and the conservation of key metabolic pathways with humans. Studies have successfully used zebrafish to uncover conserved metabolic mechanisms, identify novel disease pathways, and facilitate high-throughput screening of potential therapeutic compounds. The review also highlights the novelty of using zebrafish to model multifactorial metabolic disorders, addressing challenges such as interspecies differences in metabolism and the complexity of human metabolic disease etiology. Moving forward, future research will benefit from integrating advanced omics technologies to map disease-specific molecular signatures, applying personalized medicine approaches to optimize treatments, and utilizing computational models to predict therapeutic outcomes. By embracing these innovative strategies, zebrafish research has the potential to revolutionize the diagnosis, treatment, and prevention of metabolic disorders, offering new avenues for translational applications. Continued interdisciplinary collaboration and investment in zebrafish-based studies will be crucial to fully harnessing their potential for advancing therapeutic development.

References
1.
Kaw K, Chattopadhyay A, Guan P, Chen J, Majumder S, Duan X . Smooth muscle α-actin missense variant promotes atherosclerosis through modulation of intracellular cholesterol in smooth muscle cells. Eur Heart J. 2023; 44(29):2713-2726. PMC: 10393072. DOI: 10.1093/eurheartj/ehad373. View

2.
Cabasso O, Kuppuramalingam A, Lelieveld L, Van der Lienden M, Boot R, Aerts J . Animal Models for the Study of Gaucher Disease. Int J Mol Sci. 2023; 24(22). PMC: 10671165. DOI: 10.3390/ijms242216035. View

3.
Baschant U, Altamura S, Steele-Perkins P, Muckenthaler M, Vujic Spasic M, Hofbauer L . Iron effects versus metabolic alterations in hereditary hemochromatosis driven bone loss. Trends Endocrinol Metab. 2022; 33(9):652-663. DOI: 10.1016/j.tem.2022.06.004. View

4.
He L, Wang C, Zhang Y, Guo C, Wan Y, Li Y . Effect of Emodin on Hyperlipidemia and Hepatic Lipid Metabolism in Zebrafish Larvae Fed a High-Cholesterol Diet. Chem Biodivers. 2021; 19(2):e202100675. DOI: 10.1002/cbdv.202100675. View

5.
Zorn S, von Schnurbein J, Schirmer M, Brandt S, Wabitsch M . Measuring hyperphagia in patients with monogenic and syndromic obesity. Appetite. 2022; 178:106161. DOI: 10.1016/j.appet.2022.106161. View